Cat.#: ACPP-1290
Despition | Insulin Receptor Blocking Peptide for Immunocompetition, Immunodepletion |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1186 | Olig2 Blocking Peptide (AC1186) | 250 µg | inquiry |
ACPP-1448 | Human I TAC Protein, His (AC1448) | 5 µg | inquiry |
ACPP-1396 | Human PON2 Protein (AC1396) | 2 µg | inquiry |
ACPP-1418 | Human GAL Protein (AC1418) | 2 µg | inquiry |
ACPP-1587 | Human TMED10 Protein (AC1587) | 2 µg | inquiry |
ACPP-1529 | Human KCTD4 Protein (AC1529) | 2 µg | inquiry |
ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
ACPP-1835 | Human RP9 Protein (AC1835) | 5 µg | inquiry |
ACPP-1249 | TMPRSS2 Blocking Peptide (AC1249) | 250 µg | inquiry |
ACPP-1681 | Human CALN1 Protein (AC1681) | 1 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.